AACR Stands Against Racial Discrimination and Inequality

September 14, 2020

Eliminating Racism and Racial Inequities in Cancer Research:
A Call to Action from the American Association for Cancer Research (AACR) and Its Minorities in Cancer Research (MICR) Membership Group

The callous and brazen murder of George Floyd at the hands of a white officer of the law while Mr. Floyd begged for his life has clearly revealed a total disregard for the value of the lives of African Americans in the U.S. It is particularly disturbing to see such racist crimes being perpetrated repeatedly by law enforcement officers and others who have affirmed to support and defend the Constitution of the United States. Countless other examples, even more recently with the murders of Daniel T. Prude, Rayshard Brooks, Breonna Taylor, Tony McDade, Sean Reed, and Ahmaud Arbery, are further definitive evidence that these atrocities against humanity were based on the racist behaviors of those who took an oath to uphold justice and protect the citizens of this country.

Black lives should not only matter. Blacks should also have their basic human rights respected, so that they can flourish in a country whose Declaration of Independence provides every citizen with “certain unalienable Rights,” among which are “Life, Liberty and the pursuit of Happiness.” These rights are grounded in the self-evident truths that “all men are created equal” and should therefore be treated as such as part of their residency and/or citizenship in this country. Unfortunately, for most African Americans and other racial and ethnic minorities, pervasive and historic racism, discrimination, prejudice, and inequality limit, if not prevent, full access to these rights.

Disparities in health care are among the most significant form of inequality and injustice. Racial and ethnic minorities in the U.S. continue to experience health care disparities. As one glaring example among others, African Americans have the highest overall cancer mortality rates compared to all other racial or ethnic groups in the U.S. These stark health inequities have drawn renewed attention and substantial concern in the face of the ongoing COVID-19 pandemic, which has also disproportionately impacted communities of color. A myriad of factors influences these differences, with the most significant being socioeconomic disparities and unequal access to care. To combat and eliminate the barriers to achieving health equity for all populations, many of us in the field of cancer research have dedicated our professional lives to identifying the various factors that contribute to these cancer health disparities. Accordingly, the American Association for Cancer Research (AACR) and its Minorities in Cancer Research (MICR) membership group denounce racial injustice and oppression, and we stand in solidarity in the fight against racism, privilege, and discrimination in all aspects of life. We all have an important part to play in eradicating the social injustices that are barriers to health equity, which is one of our most basic human rights.

Membership in MICR now numbers over 5,000 racially diverse cancer scientists and physicians. MICR was formed by the AACR in the year 2000 to address racial inequalities in cancer research. MICR’s overarching mission is to prevent and cure cancer while meeting the professional needs and advancing the careers of racially and ethnically diverse cancer researchers. Since the inception of MICR, the proportion of minorities in the AACR has grown from <2% to about 11%. Concerted efforts to eliminate cancer health disparities and to assist in the professional advancement of minorities in cancer research have resulted in highly successful programs, in large part, because of the advice and counsel of members of MICR’s advisory body – the MICR Council. This Council, which consists of individuals who possess expertise in the broad spectrum of cancer research from basic science to the clinic, champions MICR’s goals that are central to supporting the careers of minority investigators and to accelerating advances against cancer in all populations.

The goals of MICR include increasing the number, participation, visibility, and recognition of minority scientists in cancer research; developing programs that address the professional needs of minority scientists in cancer research; providing diversity globally in the cancer field and within the AACR’s membership, programs, committees, and leadership; addressing the disparities in cancer incidence, morbidity, and mortality faced by racial and ethnic minorities and other underserved populations; advocating for relevant, effective science and public policies; and assuming other such roles as are deemed necessary or appropriate to MICR’s mission.

MICR continues to spearhead and guide the success of AACR’s programs and activities pertaining to the above goals. Initiatives such as planning MICR-specific activities and sessions at AACR Annual Meetings; providing program content for the series of annual AACR conferences, entitled “The Science of Cancer Health Disparities in Racial and Ethnic Minorities and the Medically Underserved”; building scientific leadership networks of minority scientists and those focused on cancer health disparities research; convening AACR Cancer Disparities Think Tanks to obtain innovative ideas on how to markedly reduce cancer incidence, morbidity, and mortality among minorities and the medically underserved; providing a voice for minority researchers to emphasize the importance of an equitable investment of federal and other resources in health equity; and advocating for effective legislation that will address the pressing need for health equity and cancer disparities research.

1. Health care is a human right. We need policies that guarantee equitable access to quality health care for all.
2. Racism needs to be addressed and eradicated throughout education, from K-12; to undergraduate, graduate, and medical school; and to post-graduate education and training.
3. Programs that bring career opportunities in health-related fields, particularly in cancer research and cancer care, to underrepresented, low-income youth need to be developed.
4. Because racism is a public health crisis, we must have serious discussions about it in the same way that we do for tobacco use, obesity, and other public health threats. Combating racism should not only be the responsibility of health care disparities researchers; like other public health crises, the elimination of racism should also be addressed as a top priority by public health professionals and cancer researchers at the national level.
5. Health care professionals have a major obligation to serve as responsible stewards of social justice and to wholeheartedly support the demands of victims of racial injustice. As but one example, to ensure the safety of individuals who are participating in social justice public events, health care professionals should make every effort to educate the public about the vital importance of personal protective equipment and social distancing as safeguards against COVID-19.

The AACR will continue to strengthen its programs for minorities in cancer research and initiate new and effective ways to achieve health equity for all populations. These actions include, but are not limited to, the following:

1. Promote health equity and markedly reduce cancer disparities in racial and ethnic minorities by embracing science and public policies that guarantee access to quality health care, increase the participation of minorities in clinical trials, and include the patient perspective.
2. Develop programs that contribute to the education, training, and mentorship of early-career minority investigators in the cancer field.
3. Collaborate with the nation’s cancer centers and Historically Black Colleges and Universities (HBCUs) to launch strategic initiatives that further the careers of minority cancer researchers.
4. Work to stimulate the nominations of minority scientists and physicians for scientific merit awards as well as for election as Fellows of the AACR Academy and members of the AACR Board of Directors.
5. Increase the number of underrepresented minority scientists and physicians on Boards, Councils, Editorial Boards (and as reviewers), scientific program planning committees of the Annual Meeting and other major scientific conferences and workshops, other AACR committees, and NIH study sections, thus promoting diversity and inclusion at leadership levels in cancer science and medicine.
6. Encourage applications from underrepresented groups to AACR’s research grants and strongly urge mentors to support the nominations of their mentees who come from diverse backgrounds.
7. Raise philanthropic funds for dedicated minority and targeted disparities grant mechanisms, as well as advocate for innovative grant mechanisms from the federal government, corporate entities, and foundations, to increase diversity in the conduct of cancer research and patient care.
8. Continue to produce the AACR’s Annual Cancer Disparities Progress Report, and include the expert views of MICR in content development.
9. Continue to increase the number of plenary sessions and mini-symposia focused on cancer disparities research at AACR Annual Meetings and other AACR conferences, so that the discussion about health disparities and the inclusion of underrepresented minorities across the spectrum of cancer research is not limited only to cancer disparities conferences. Mainstream this scientific content in relevant topical sessions at scientific meetings.
10. Provide an ongoing platform to foster an open and honest dialogue about racism and racial and ethnic inequities in cancer research and patient care.

In summary, we cannot allow the recently witnessed inhumanities against people of color to disappear from our minds. Systemic problems require systemic solutions. The AACR will continue to actively foster impactful science and public policies that benefit everyone equally, while at the same time dedicate its efforts to the elimination of cancer health disparities and the inclusion and recognition of the contributions of minority investigators in cancer research. Further the participation of minorities on clinical trials will remain a top priority.

We must seize this moment in time to make long-term positive change that leads to racial equality, social justice, and health equity for every American. To quote Dr. Martin Luther King, Jr., “Our lives begin to end the day we become silent about things that matter.”

June 4, 2020

The American Association for Cancer Research (AACR) is outraged and saddened about the pervasive racism and social injustices toward African Americans in our country and all people of color around the world. As a scientific organization focused on the conquest of cancer whose core values include equality, diversity, and inclusion, we stand in solidarity in denouncing the recent tragic deaths of George Floyd, Tony McDade, Breonna Taylor, Sean Reed, Ahmaud Arbery, and countless others before them whose lives have been taken because of racism. Along with our AACR members, patient advocates, patients with cancer and cancer survivors, staff members, and all others around the world, we wish to voice our anguish and deep frustration with the systemic injustices that have led to significant social and health inequities among racial and ethnic minorities. We deplore discrimination, racism, and racial injustice in any form, including the long-standing disenfranchisement of Black communities.  Racial and ethnic minorities in the United States and around the world continue to experience health care inequities, including a disproportionate burden of cancer. As a glaring example, African Americans have the highest overall cancer mortality rates compared to all other racial or ethnic groups in the U.S. These stark health inequities have drawn renewed attention and concern in the face of the ongoing COVID-19 pandemic, which has also disproportionately impacted communities of color. For example, African Americans account for 13 percent of the U.S. population, but about 23 percent of the deaths from the novel coronavirus. Research is driving tremendous progress against cancer and other human diseases, but the grim reality is that these advances have not benefited everyone equally. Progress has come too slowly for people of color, and the monumental cost of health disparities in terms of health care inequities, premature deaths, and the impact on communities must be immediately addressed.   The AACR will continue to actively promote high-quality, impactful science and policies that are focused on eliminating cancer disparities in racial and ethnic minorities. To accomplish this vitally important goal, we will continue to foster advances against cancer and COVID-19 disparities through our state-of-the-art conferences and scientific journals and publications. Further, we will champion the work of minority and other researchers, physicians, and advocates who are working tirelessly to eradicate health disparities and to prevent and cure cancer in all populations. The AACR is deeply committed to realizing the vision of social justice and equality for all Black and other racial and ethnic minorities, both nationally and globally. We stand in solidarity against racial discrimination and inequality, and will work with our diverse membership to help create a world that achieves equity, unity, and justice for all.   Elaine R. Mardis, PhD, FAACR, President Antoni Ribas, MD, PhD, FAACR, President-Elect David A. Tuveson, MD, PhD, FAACR, President-Elect Designate Elizabeth M. Jaffee, MD, FAACR, Immediate Past President William N. Hait, MD, PhD, FAACR, Treasurer and Past President Margaret Foti, PhD, MD (hc), Chief Executive Officer On behalf of the AACR Board of Directors John D. Carpten, PhD, Chair, Minorities in Cancer Research Council